Publicaties

Vijf publicaties die een goed beeld geven van mijn werk. De volledige lijsten staan hieronder.

• Iorizzo M, Pampaloni F, Apalla Z, … Galimont-Collen A, et al. Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patients. J Eur Acad Dermatol Venereol. 2026. Lid van de EADV Task Force Dermatology for Cancer Patients.
• Apalla Z, Freites-Martinez A, Grafanaki K, … Galimont A, et al. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol. 2025. Internationale consensus.
• NVDV, 2026: Voeding, Leefstijl en de Huid: vijf leefstijlmodules in de richtlijnen Psoriasis en Constitutioneel Eczeem. Vicevoorzitter van de richtlijnwerkgroep.
• IKNL, 2022: Richtlijn Palliatieve Zorg voor Kinderen, module Huidzorg. Voorzitter van de werkgroep.
• ProVoet, 2025: Protocol Schimmelinfecties aan de voeten (patiëntenfolder Voetschimmel). Eerste auteur.

Mijn artikelen staan onder de naam Galimont-Collen. Oudere artikelen staan onder Collen. Je vindt ze ook op PubMed.

• van der Gang LF, Boesjes CM, Zuithoff NPA, … Galimont-Collen AFS, et al. Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry. Allergy. 2026;81(2):609-13.
• Iorizzo M, Pampaloni F, Apalla Z, … Galimont-Collen A, et al. Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patients. J Eur Acad Dermatol Venereol. 2026;40(2):185-98.
• Apalla Z, Freites-Martinez A, Grafanaki K, … Galimont A, et al. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol. 2025;39(4):730-41.
• Vink M, Coppoolse H, Bergmans A, … Galimont-Collen A, et al. Exploring transmission dynamics of the Sarcoptes scabiei mite in humans by combining molecular typing and epidemiological variables, the Netherlands 2016-2023. Parasit Vectors. 2024;17(1):419.
• van Teunenbroek KC, Mulder RL, Ahout IML, … Galimont-Collen AFS, et al. A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatment. BMC Palliat Care. 2024;23(1):72.
• van Teunenbroek KC, Kremer LCM, Verhagen AAE, et al. Palliative care for children: methodology for the development of a national clinical practice guideline. BMC Palliat Care. 2023;22(1):193.
• Klösters FM, Van Winden MEC, Angenent FR, … Galimont-Collen AFS, et al. Reasons for Dermatology Consultations in Nursing Homes and the Estimated Potential of Teledermatology as a Triage Tool. Acta Derm Venereol. 2022;102:adv00827.
• Çiftçi Z, Clabbers JMK, Galimont-Collen AFS, Gostyński A. Huidafwijkingen bij covid-19. Ned Tijdschr Geneeskd. 2020;164:D5443.
• Galimont-Collen AF, Vos LE, Lavrijsen AP, Ouwerkerk J, Gelderblom H. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer. 2007;43(5):845-51.
• de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol. 2006;126(3):569-74.
• Delfos NM, Collen AF, Kroon FP. Demodex folliculitis: a skin manifestation of immune reconstitution disease. AIDS. 2004;18(4):701-2.
• Schippers EF, Beersma MF, Lavrijsen AP, Collen A, Kroes AC. A case of simultaneous primary HIV-1 and CMV infections. J Clin Virol. 2004;29(2):134-6.
• Collen A, Hanemaaijer R, Lupu F, et al. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood. 2003;101(5):1810-7.
• Collen A, Maas A, Kooistra T, et al. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation. Blood. 2001;97(4):973-80.
• van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci. 2001;936:426-37.
• Collen A, Smorenburg SM, Peters E, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000;60(21):6196-200.
• Braat EA, Collen A, Jie AF, Grimbergen JM, Rijken DC. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells. Biochim Biophys Acta. 2000;1497(3):351-8.
• van Hinsbergh VW, Collen A, Koolwijk P. Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors. Ann Oncol. 1999;10 Suppl 4:60-3.
• Kroon ME, Koolwijk P, van Goor H, … Collen A, et al. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol. 1999;154(6):1731-42.
• Collen A, Koolwijk P, Kroon M, van Hinsbergh VW. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis. 1998;2(2):153-65.